Anti-connective tissue growth factor (CTGF/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosis.
Katsunari MakinoTomoko MakinoLukasz StawskiKenneth E LipsonAndrew LeaskMaria TrojanowskaPublished in: Arthritis research & therapy (2017)
Our data indicate that inhibition of CTGF signaling presents an attractive therapeutic approach in SSc.